Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.
about
Risk factors for oligodendroglial tumors: a pooled international studyEnhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomicsMultiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumorsOne hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literatureValidation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.Survey of treatment recommendations for anaplastic oligodendrogliomaUpdate on molecular findings, management and outcome in low-grade gliomas.New perspectives for the diagnosis and treatment of oligodendroglioma.Predictive and prognostic markers in neuro-oncology.Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?Classifying the medulloblastoma: insights from morphology and molecular genetics.Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersGenetic alterations and signaling pathways in the evolution of gliomas.Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosisOligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.The future of high-grade glioma: Where we are and where are we going.Leptomeningeal disease in oligodendroglial tumors: a population-based study.EPMA position paper in cancer: current overview and future perspectives.Chemotherapy of anaplastic oligodendroglial tumours.Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsetsDetection of 1p19q deletion by real-time comparative quantitative PCR.Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.Molecular markers of gliomas: a clinical approach.Designing clinical trials for brain tumors: the next generation.Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution.Prognostic markers in gliomas.Molecular genetics, imaging and treatment of oligodendroglial tumours.Predictive and prognostic factors for gliomas.Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?Exploitation of adaptive evolution in glioma treatment.Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis.
P2860
Q23910577-03CEA3F6-F2A1-4845-9083-A5AF7F1AAED9Q24618080-367703C8-D3B2-4B27-818A-A2C99586968BQ24685905-88992303-B86D-4519-8C14-1EEFE4C01482Q26863688-336C7C43-8897-4904-BEDF-EE2A9B909BECQ30425164-D73F3851-0CC6-4618-B2AB-CA3D479F2CABQ30441461-0AA62C11-74E8-4574-BB23-B8CF6699246FQ30452178-0007F199-02A6-4FE3-90C9-E070388D889BQ33183924-58E54A0C-E0EC-4330-B261-69BB799D09BCQ33311133-D733C28A-8F5D-4603-8FEB-83EA93AA0B8FQ33638116-01B3B1E5-643A-4A32-AF55-A0C7017202B9Q34132860-9343AC4F-62E7-4E73-BC38-B1E3FFF47DD3Q34783428-A70C211D-CF0F-4AD8-BC72-B1763C0FE5D6Q34815207-405DCE57-BB47-4EC2-8BB0-79546024C616Q35001574-C293FE7F-8C26-4082-8BE2-B716626B97F9Q35038477-DDD178F2-26AB-4652-9105-684A06FBB491Q35063647-281B501B-C969-4D42-B0F2-68CE401A5810Q35114090-BD7A468B-5544-408C-AE8B-AFC51A2691EEQ35205863-B34DC1D9-3503-4BFF-9408-7982283C2F5AQ35532215-C00B24A7-457E-4255-A40D-DAA31977CFD9Q35680586-CDA186D6-1CC6-464E-A91A-EFE47AA83B84Q35747448-317EA4B8-ADB1-400B-8AA0-8F17130AF093Q35789635-15E1E81C-E3B8-4886-B2C2-4D0356BC2B1DQ36096036-8A6E0F4D-7B97-435B-8924-6490A10CB1B6Q36445546-51D7495A-B8FE-4904-A4AB-98B353E48246Q36523374-0ABFFF56-4EBF-459F-B777-8665DD643287Q36681517-A14F5C29-EE81-40FB-B282-7ADB421E469FQ37037132-DD1063F0-7F10-490B-91BD-5DC42EBEAC3EQ37225840-883E180B-CF97-425F-9518-A056E3172B65Q37284303-22BC5D85-EE4E-447E-9AA4-258B3987A8ECQ37312716-C4802704-F92A-4A7B-8CF1-36D168A78999Q37350203-98A7BBC6-6F67-42CC-A1C8-2C884A76586DQ37395331-86463DFB-D210-4AC8-ABD1-4F544029CC01Q37471678-17A2A7D9-9E8E-4BB2-9669-354F70326B68Q37750781-7E3D5DB3-25BA-490B-978C-E19BCE63124FQ37784709-A5E4267C-C0AD-4EA4-B454-825449C9E60CQ37873473-B3253EDD-757B-4996-B8DD-050ADD4AC2DBQ38062793-91DD930A-21D6-4441-9F82-523BDC82824EQ38131489-D08D5A71-C7A2-4901-9453-6693C73B1DECQ38457106-E8CD3841-4356-4F45-989A-BE7C2DED3C06Q40229295-5157B86B-DEDB-4A79-A20C-662679F3A147
P2860
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Allelic loss of chromosome 1p ...... ients with oligodendrogliomas.
@en
type
label
Allelic loss of chromosome 1p ...... ients with oligodendrogliomas.
@en
prefLabel
Allelic loss of chromosome 1p ...... ients with oligodendrogliomas.
@en
P2093
P921
P1476
Allelic loss of chromosome 1p ...... tients with oligodendrogliomas
@en
P2093
B J Fisher
D R Macdonald
J G Cairncross
M C Zlatescu
P304
P356
10.1016/S0360-3016(00)00703-3
P407
P50
P577
2000-10-01T00:00:00Z